Protective effect of epigallocatechin gallate in ischemia-reperfusion injury of rat skeletal muscle.

PMID:  J Surg Res. 2019 Dec 6 ;247:1-7. Epub 2019 Dec 6. PMID: 31816476 Abstract Title:  Protective Effect of Epigallocatechin Gallate in Ischemia-Reperfusion Injury of Rat Skeletal Muscle. Abstract:  BACKGROUND: Reactive oxygen species-induced cell injury has been considered to be one of the main etiologic factors in ischemia-reperfusion injury (IRI). As a potential antioxidant agent, …

Protective effect of epigallocatechin gallate on endothelial disorders in atherosclerosis.

PMID:  J Cardiovasc Pharmacol. 2019 Dec 30. Epub 2019 Dec 30. PMID: 31895874 Abstract Title:  Protective effect of epigallocatechin gallate on endothelial disorders in atherosclerosis. Abstract:  Healthy vascular endothelial cells regulate vascular tone and permeability, prevent vessel wall inflammation, enhance thromboresistance, and contribute to general vascular health. Furthermore, they perform important functions including the production …

EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells.

PMID:  J Cell Physiol. 2020 Jan 14. Epub 2020 Jan 14. PMID: 31943177 Abstract Title:  EGCG regulates CTR1 expression through its pro-oxidative property in non-small-cell lung cancer cells. Abstract:  Copper transporter 1 (CTR1) plays an important role in increasing cisplatin intake. Our previous studies showed that CTR1 expression was upregulated by (-)-epigallocatechin-3-gallate (EGCG), a green tea …

ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma.

PMID:  Int J Clin Exp Pathol. 2019 ;12(9):3222-3234. Epub 2019 Sep 1. PMID: 31934166 Abstract Title:  ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma. Abstract:  Epigallocatechin-3-gallate (EGCG) is a natural product with potential anti-cancer property whose direct target has not been identified. This study intended to investigate ERα36, a new isoform of estrogen …

These findings suggest that tanshinone IIA may protect lung from silica damage.

PMID:  Drug Des Devel Ther. 2019 ;13:4275-4290. Epub 2019 Dec 18. PMID: 31908414 Abstract Title:  The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation. Abstract:  Purpose: Silicosis is an occupational disease caused by inhalation of silica and there are no effective drugs to treat …

Potential ameliorative effects of epigallocatechin-3-gallate against cigarette smoke exposure induced renal and hepatic deficits.

PMID:  Ecotoxicol Environ Saf. 2020 Jan 13 ;191:110202. Epub 2020 Jan 13. PMID: 31945511 Abstract Title:  Potential ameliorative effects of epigallocatechin-3-gallate against cigarette smoke exposure induced renal and hepatic deficits. Abstract:  The environmental pollution caused by cigarette smoke (CS) seriously endangers people's health. Epigallocatechin-3-gallate (EGCG) is the most abundant catechin in green tea. In this …

Tanshinone IIA can effectively improve liver fibrosis and liver function.

PMID:  Evid Based Complement Alternat Med. 2019 ;2019:7514046. Epub 2019 Dec 13. PMID: 31915451 Abstract Title:  Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis. Abstract:  Background: Liver fibrosis is a serious human health problem, and there is a need for specific antifibrosis drugs in the clinic. Tanshinone IIA …

Tanshinone IIA reduces oxidized low-density lipoprotein-induced inflammatory responses.

PMID:  Int J Clin Exp Pathol. 2019 ;12(10):3791-3798. Epub 2019 Oct 1. PMID: 31933767 Abstract Title:  Tanshinone IIA reduces oxidized low-density lipoprotein-induced inflammatory responses by downregulating microRNA-33 in THP-1 macrophages. Abstract:  Atherosclerosis is a leading cause of cardiovascular diseases. Oxidized low-density lipoprotein (ox-LDL) is commonly used to construct atherosclerosis cell models. Macrophages-secreted pro-inflammatory factors play …

Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease.

PMID:  Mech Ageing Dev. 2020 Jan 14:111209. Epub 2020 Jan 14. PMID: 31953123 Abstract Title:  Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease. Abstract:  Alzheimer's disease (AD) is the most common form of dementia. Currently, there is no effective medication for the prevention or treatment of AD. …

Antibacterial and immunomodulator activities of virgin coconut oil against Staphylococcus aureus.

PMID:  Heliyon. 2019 Oct ;5(10):e02612. Epub 2019 Oct 20. PMID: 31673647 Abstract Title:  Antibacterial and immunomodulator activities of virgin coconut oil (VCO) against. Abstract:  Antibiotics have components to inhibit infections against, but they depend on judicious use to minimize the incidence of resistance forms. Strategies to improve the current situation include research in finding a …

Design a site like this with WordPress.com
Get started